Copyright Reports & Markets. All rights reserved.

Global Daridorexant Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Daridorexant Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 25mg
    • 1.3.3 50 mg
  • 1.4 Market Analysis by Dosage Form
    • 1.4.1 Overview: Global Daridorexant Consumption Value by Dosage Form: 2021 Versus 2025 Versus 2032
    • 1.4.2 Tablets
    • 1.4.3 Other
  • 1.5 Market Analysis by Research Attributes
    • 1.5.1 Overview: Global Daridorexant Consumption Value by Research Attributes: 2021 Versus 2025 Versus 2032
    • 1.5.2 Original Drug
    • 1.5.3 Generic Drug
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global Daridorexant Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Hospital and Clinic
    • 1.6.3 Retail Pharmacies
    • 1.6.4 Other
  • 1.7 Global Daridorexant Market Size & Forecast
    • 1.7.1 Global Daridorexant Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Daridorexant Sales Quantity (2021-2032)
    • 1.7.3 Global Daridorexant Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Idorsia
    • 2.1.1 Idorsia Details
    • 2.1.2 Idorsia Major Business
    • 2.1.3 Idorsia Daridorexant Product and Services
    • 2.1.4 Idorsia Daridorexant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Idorsia Recent Developments/Updates
  • 2.2 Simcere Pharmaceutical
    • 2.2.1 Simcere Pharmaceutical Details
    • 2.2.2 Simcere Pharmaceutical Major Business
    • 2.2.3 Simcere Pharmaceutical Daridorexant Product and Services
    • 2.2.4 Simcere Pharmaceutical Daridorexant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Simcere Pharmaceutical Recent Developments/Updates
  • 2.3 Nxera Pharma
    • 2.3.1 Nxera Pharma Details
    • 2.3.2 Nxera Pharma Major Business
    • 2.3.3 Nxera Pharma Daridorexant Product and Services
    • 2.3.4 Nxera Pharma Daridorexant Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Nxera Pharma Recent Developments/Updates

3 Competitive Environment: Daridorexant by Manufacturer

  • 3.1 Global Daridorexant Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Daridorexant Revenue by Manufacturer (2021-2026)
  • 3.3 Global Daridorexant Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Daridorexant by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Daridorexant Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Daridorexant Manufacturer Market Share in 2025
  • 3.5 Daridorexant Market: Overall Company Footprint Analysis
    • 3.5.1 Daridorexant Market: Region Footprint
    • 3.5.2 Daridorexant Market: Company Product Type Footprint
    • 3.5.3 Daridorexant Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Daridorexant Market Size by Region
    • 4.1.1 Global Daridorexant Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Daridorexant Consumption Value by Region (2021-2032)
    • 4.1.3 Global Daridorexant Average Price by Region (2021-2032)
  • 4.2 North America Daridorexant Consumption Value (2021-2032)
  • 4.3 Europe Daridorexant Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Daridorexant Consumption Value (2021-2032)
  • 4.5 South America Daridorexant Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Daridorexant Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Daridorexant Sales Quantity by Type (2021-2032)
  • 5.2 Global Daridorexant Consumption Value by Type (2021-2032)
  • 5.3 Global Daridorexant Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Daridorexant Sales Quantity by Application (2021-2032)
  • 6.2 Global Daridorexant Consumption Value by Application (2021-2032)
  • 6.3 Global Daridorexant Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Daridorexant Sales Quantity by Type (2021-2032)
  • 7.2 North America Daridorexant Sales Quantity by Application (2021-2032)
  • 7.3 North America Daridorexant Market Size by Country
    • 7.3.1 North America Daridorexant Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Daridorexant Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Daridorexant Sales Quantity by Type (2021-2032)
  • 8.2 Europe Daridorexant Sales Quantity by Application (2021-2032)
  • 8.3 Europe Daridorexant Market Size by Country
    • 8.3.1 Europe Daridorexant Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Daridorexant Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Daridorexant Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Daridorexant Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Daridorexant Market Size by Region
    • 9.3.1 Asia-Pacific Daridorexant Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Daridorexant Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Daridorexant Sales Quantity by Type (2021-2032)
  • 10.2 South America Daridorexant Sales Quantity by Application (2021-2032)
  • 10.3 South America Daridorexant Market Size by Country
    • 10.3.1 South America Daridorexant Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Daridorexant Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Daridorexant Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Daridorexant Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Daridorexant Market Size by Country
    • 11.3.1 Middle East & Africa Daridorexant Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Daridorexant Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Daridorexant Market Drivers
  • 12.2 Daridorexant Market Restraints
  • 12.3 Daridorexant Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Daridorexant and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Daridorexant
  • 13.3 Daridorexant Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Daridorexant Typical Distributors
  • 14.3 Daridorexant Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Daridorexant market size was valued at US$ 179 million in 2025 and is forecast to a readjusted size of US$ 1050 million by 2032 with a CAGR of 29.1% during review period.
    Daridorexant, sold under the brand name Quviviq, is a medication used to treat insomnia. It is an orexin receptor antagonist, specifically targeting both OX1 and OX2 receptors. This dual mechanism helps regulate sleep-wake cycles, making it effective for improving sleep onset and maintenance. Unlike benzodiazepines or Z-drugs, daridorexant does not interact with GABA receptors, offering a distinct way to manage sleep disorders.
    The medication is taken orally and has a relatively short elimination half-life of around 8 hours, with a peak effect occurring within 1 to 2 hours after administration. Common side effects include headache, somnolence (sleepiness), and fatigue. Daridorexant was approved for use in the United States in January 2022 and became available in May 2022. It was also approved in the European Union in April 2022, marking the first orexin receptor antagonist to be available there. However, it is classified as a Schedule IV controlled substance in the United States, indicating a modest potential for misuse.
    Daridorexant provides an alternative to traditional sleep medications, offering a distinct mechanism of action that may reduce the risk of dependence and tolerance associated with other sleep aids.In 2024, global sales of Daridorexant reached 3.94 million tablets, with an average unit price of USD 17.56 per tablet and an average gross profit margin of 71.2%.
    In the U.S. and Europe, Daridorexant has entered a phase of rapid commercial expansion, supported by favorable clinical differentiation and growing physician adoption. Within the European Union, it is the most recent DORA approved by the EMA for improving both nighttime sleep and daytime functioning—an indication that broadens its clinical appeal beyond sleep onset and maintenance alone. Compared with other DORAs, its pharmacokinetic profile and well-balanced efficacy-safety ratio contribute to higher treatment adherence and positive real-world outcomes.
    From a commercial standpoint, Daridorexant’s global rollout reflects a strategic blend of licensing, distribution, and market access initiatives. Regional partnerships enable efficient regulatory navigation and localized market penetration, ensuring coverage across hospitals, retail pharmacies, and online prescription platforms. Reimbursement listings in select countries further enhance patient accessibility, reinforcing uptake momentum. The integration of pharmacovigilance and patient-reported outcomes into post-marketing surveillance also supports sustained physician confidence and long-term safety validation.
    Market uptake has been strongest in North America, Western Europe, and Japan, where supportive healthcare infrastructure and awareness campaigns accelerate adoption. In emerging markets such as China, Daridorexant’s entry underscores the expanding recognition of DORA-based therapeutics as the next-generation standard for insomnia care. Continued emphasis on education, real-world data generation, and stable supply chains will be critical to maintaining its growth trajectory.
    Overall, Daridorexant exemplifies the evolution of insomnia therapeutics toward mechanism-driven, safety-conscious innovation. Its combination of differentiated pharmacology, robust clinical data, and strategic commercialization positions it as a leading agent in the global sleep medicine landscape—poised to define the post-benzodiazepine era of pharmacological sleep management.
    This report is a detailed and comprehensive analysis for global Daridorexant market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Daridorexant market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Daridorexant market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Daridorexant market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Daridorexant market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Daridorexant
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Daridorexant market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Idorsia, Simcere Pharmaceutical, Nxera Pharma, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Daridorexant market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    25mg
    50 mg
    Market segment by Dosage Form
    Tablets
    Other
    Market segment by Research Attributes
    Original Drug
    Generic Drug
    Market segment by Application
    Hospital and Clinic
    Retail Pharmacies
    Other
    Major players covered
    Idorsia
    Simcere Pharmaceutical
    Nxera Pharma
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Daridorexant product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Daridorexant, with price, sales quantity, revenue, and global market share of Daridorexant from 2021 to 2026.
    Chapter 3, the Daridorexant competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Daridorexant breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Daridorexant market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Daridorexant.
    Chapter 14 and 15, to describe Daridorexant sales channel, distributors, customers, research findings and conclusion.

    Buy now